BioSpace News Archive

Lustgarten Foundation funded researchers at Johns Hopkins University have released promising results showing that computers can be trained to detect pancreatic tumors in CT scans, as reported in the American Journal of Roentgenology.

Follows $25 Million in Corporate Commitment Last December

Hearing aid manufacturer seeks nominations for individuals with hearing loss and hearing care professionals who are making an impact in the world

The Longest Running Cannabis Terpene Laboratory Offers New Formulation and Delivery Applications for Terpenes in Water-Based Products of Any Kind

Fengate Asset Management announced that it has closed total capital commitments of $1.1 billion for Fengate Core Infrastructure Fund III and affiliated vehicles, exceeding both its $750 million target and initial $1 billion hard cap.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Venclexta® (venetoclax) in combination with Gazyva® (obinutuzumab) for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

U.S. military personnel will now be able to experience safe, drug-free muscle recovery and chronic pain relief due to a new government contract with Cryo Innovations.

“Scaling Up Stevia” won for Best Feature Article, Trade Category

Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings – will host its New York Oncology Insight Summit at The Barclay Intercontinental Hotel in New York City on May 16, 2019.

The Michigan Chamber of Commerce issued the following statement in response to Michigan Attorney General Dana Nessel’s nationwide search for outside legal counsel to pursue lawsuits against companies that manufacture opioid medications and polyfluoroalkyl substances.